Investors

Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

Stock Quote

Price

Change

High

View DetailsStock Lookup

Copyright West LLC. Minimum 15 minutes delayed.

Events & Presentations
Events & Presentations
Annual Report and Proxy Statement
Press Releases
Date Title and Summary
Toggle Summary Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
SAN DIEGO , June 13, 2019 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi , the Company's President and Chief Executive Officer, will present a corporate update at the JMP Securities Life Sciences Conference on Wednesday, June 19, 2019 , at 1:30 PM
General
Toggle Summary Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community
- ELEVATE UC Phase 3 global program site initiations - New data for both etrasimod and olorinab SAN DIEGO , May 17, 2019 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has initiated sites for its ELEVATE UC Phase 3 global program to evaluate etrasimod 2 mg in
General